From Patient Voices to Action: Understanding the PH Global Survey

29 August 2025

A Webinar for Patients and Carers on PHGPS European Findings 

This patient-focused webinar explored the findings from the Pulmonary Hypertension Global Patient Survey (PHGPS) – with a focus on adult data across Europe.

The session:

  • Highlighted key findings from the PHGPS
  • Focused on three major topics: time to diagnosis, quality of life, and access to care
  • Compared findings across European countries
  • Broke down the 10 Calls to Action and how they aim to improve PH care globally
  • Empowered patients to use the data in personal advocacy and shared decision-making

Speakers

  • Hall Skaara, PHA Europe
  • Wendy Gin-Sing, Imperial College Healthcare NHS Trust 

In partnership with

  • PHA Europe
  • European Lung Foundation

Featuring

Hall Skaara, PHA Europe
Wendy Gin-Sing, Imperial College Healthcare NHS Trust
Share:

Other materials on this topic

9 June 2025

The Role of Telehealth in PAH Management: Benefits, Barriers, and Solutions

Telehealth utilization increased during the coronavirus disease-2019 (COVID-19) pandemic, which encouraged remote patient management. The identification of optimal strategies to enhance telehealth and address barriers to its use for patients with pulmonary arterial hypertension (PAH) may improve patient outcomes. 

Pulmonary Circulation
2 April 2025

Hank the Heart and Animation-Based Education for Pulmonary Hypertension

Pulmonary hypertension (PH) is a rare, complex disease affecting both children and adults. Efforts to provide health education are imperative as health literacy impacts patient and caregiver capacity to acquire, process, and understand health information and make informed health decisions. 

Pulmonary Circulation
3 February 2025

Pulmonary Hypertension: A Personal Journey

My first clinical experience with Pulmonary Hypertension occurred when, as a resident at Duke University Hospital in the late 1970's, a patient with “primary pulmonary hypertension (PPH)” was admitted with right heart failure.

Pulmonary Circulation
20 December 2024

Relationship Between Sexual Function, Health-Promoting Behaviors, and Quality of Life in Female Patients With Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a chronic progressive exacerbation of cardiopulmonary vascular disease. The patients' exercise endurance decreased progressively and the survival rate was low. Current basic therapy and targeted drug therapy can improve the quality of life (QoL) of PAH patients, but the long-term efficacy and prognosis are not good.

Pulmonary Circulation